Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

CGT9486-21-301

Trial Overview

Official Title

A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER CLINICAL STUDY OF CGT9486+SUNITINIB VS SUNITINIB IN SUBJECTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC GASTROINTESTINAL STROMAL TUMORS

 

Study Purpose

The purpose of this part of the research study is to evaluate how CGT9486 plus sunitinib affects GIST compared to just treatment with sunitinib alone.

 

Diagnosis

Gastrointestinal Stromal Tumors that cannot be surgically removed, have come back after initial treatment, or have spread to other parts of the body

Eligibility

Must have locally advanced, metastatic, and/or unresectable GIST, and have received prior therapy with imatinib.

Intervention

CGT9486+SUNITINIB VS SUNITINIB

For more information visit Clinicaltrials.gov

Key Participation Requirements
Trial Location(s)
Methodist Estabrook Cancer Center
Gender
Male or Female
Age
19 and Older
Enrollment Status
Recruiting
Phase
Phase III